Research Article India

10.26502/jbsb.5107021

Re-Profiling of US-FDA Approved Drugs for COVID-19 by In-silico Studies

Published On: 2021-06-29 Authors: Akash Parab, Dr Gaganjyot Kaur, Abhishek Sharma, Gursewak Bhuller, Sharvari Chitnis, Ankit Chindaliya, Mayur Weta